Welcome to Drug and Alcohol Treatment
| ||
Cdt Drug Treatment Article
This is a selection made from among articles on Cdt Drug Treatment. For a permanent link to this article, or to bookmark it for future reading, click here.
Arizona Drug Rehab Finding Help in Arizona
from:
The state of Arizona has one of the worst drug problems in the United States. Historically and currently, the state is known as a transhipment location for a variety of drugs, including heroin, cocaine and marijuana, which are imported from other countries. As a result, these and other drugs are widely available in the state, and their abuse is common. There are probably few states that require the presence of rehabilitation centers as this one does - thankfully Arizona drug rehab centers are some of the best in the world.
There is a wide range of treatment centers in Arizona that employ a range of different techniques to help the patient break their addiction. Some of these will have particular specialisations, which might be more appropriate for certain types of patient, so it is always sensible to find out as much as you can about an Arizona drug rehab before making an appointment. Services like drugs-rehabs.org will be able to provide you with treatment center listings in your area, with basic descriptive information to help you make the best decision for you. Some of the features that might help influence your decision for the best:
· Does the center have a particular religious affiliation? While Christian centers, for example, might be willing to accept non-Christian patients, many will feel more comfortable in a non-denominational center, or one that practises their own faith.
· What type of care is available? Ensure that your chosen center has a program specifically for drug detoxification. Other kinds of therapy will be useful, but it will be necessary for the patient to make a commitment to ceasing drug use also.
· What facilities are available? Some Arizona drug rehab centers will only cater to outpatients, which may not offer enough support to a badly addicted patient. Find a center that provides inpatient care.
· What payments options are available? Does the center accept Medicare, Medicaid or private health insurance? If you are not involved with any of these programs, can your center offer sliding scale payments?
There are many high quality Arizona drug rehab treatment centers available, but it is important that you choose the best one for you or your loved one. Never hesitate to contact a center directly to find out more about their facilities, or to find out whether they can cater to any special needs you might have. The right treatment center is out there, and with a little investment of time and effort, you will find it. The best treatment for you or your loved one will be well worth it.
About Author
Jeff Lakie is the founder of Rehab Resources a website providing information on drug and alcohol rehabilitaiton treatments
Source: ArticleTrader.com
Cdt Drug Treatment Specific links
Cdt Drug Treatment News
Sentences handed down
• William Travis Staab, 23, of Alma did not resist a petition to revoke a drug court sentence he received June 1, 2011, for theft of property. He was sentenced to two years at a regional correction facility where he will complete the long-term drug treatment program.
Read more...Mental Health Facility Gains National Recognition
Duluth, MN (Northland's NewsCenter) - Each month we lose two children or young adults to suicide or drug overdose. It's an alarming statistic associated with mental health problems across the Northland. A new facility is quickly coming together to help treat our kids and its already gaining national attention. Kevin Jacobsen gets an inside look.
Read more...Pre-trial hearing set for grocery store robbery suspect
TAZEWELL COUNTY -- A man charged with aggravated robbery of a Pekin Kroger store has pleaded not guilty.
Read more...Tokai Pharmaceuticals’ Galeterone Phase 1 Data in Patients with Advanced Prostate Cancer to be Presented at ASCO ...
Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced that additional data from a Phase 1 safety and proof-of-concept study evaluating lead candidate, galeterone , in patients with castration-resistant prostate cancer will be highlighted in a poster presentation titled, “Phase I clinical trial of galeterone , a ...
Read more...Active Biotech and Ipsen to present Tasquinimod Phase II Overall Survival data at the 2012 ASCO Annual Meeting
Lund (Sweden) and Paris (France), May 18, 2012, Active Biotech (NASDAQ OMX NORDIC: ACTI) and Ipsen (Euronext: IPN; ADR: IPSEY) will present tasquinimod (TASQ), their prostate cancer drug candidate, at ...
Read more...State To Collect $3.3 Million In Drug Suit Settlements
LITTLE ROCK--Arkansas and more than 40 other states have joined in separate settlements totaling $1.6 billion with Abbott Laboratories over allegations of illegal off-label marketing of the anti-seizure drug Depakote, state Attorney General Dustin McDaniel announced today.
Read more...Pleas entered in circuit court
• Troy Dewayne Ball, 37, of Alma pleaded guilty to possession of methamphetamine, possession of drug paraphernalia and speeding and was sentenced to two years at a regional correctional facility to be followed by an eight-year suspended prison sentence.
Read more...Amgen's BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed ...
THOUSAND OAKS, Calif., May 16, 2012 /PRNewswire/ --Â Amgen (AMGN) today announced updated results from a Phase 2 study that showed treatment with blinatumomab (AMG 103) helped achieve a high-rate ...
Read more...Press Release
Tokai Pharmaceuticals Inc. Posted on:17 May 12 Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced that additional data from a Phase 1 safety and proof-of-concept study evaluating lead candidate, galeterone (TOK-001), in patients with castration-resistant prostate cancer (CRPC) will be highlighted in a poster ...
Read more...Analysis Of Rilotumumab (AMG 102) Data Identifies A Potential Predictive Biomarker For Patients With Gastric Or ...
THOUSAND OAKS, Calif., May 16, 2012 /PRNewswire/ --Â Amgen (AMGN) announced today results from an exploratory biomarker analysis evaluating MET expression as a predictor of clinical response to ...
Read more...